Fri, Nov 19th, 2021 - 8:06am
June 02, 2022 - 9:46am | By Kyle Cornell
(Washington, DC) -- The first COVID vaccine for kids as young as six months old could be approved in just two weeks.
That's when an FDA committee will meet to discuss Pfizer's request. The company says three doses are safe and offer strong protection. In fact, trial results show the vaccine produced a similar immune response as two doses in 16-to-25-year-olds.
The FDA will also consider Moderna's vaccine for the same age group and children six through 17.
